CDH1 and ovarian cancer: Five studies (according to the Kaplan–Meier test) clearly indicated that patients with primary ovarian cancer characterized by reduced expression of E-cadherin had significantly shorter OS than patients whose tumor tissue highly expressed E-cadherin [40,41,42,43,44].